Single-Use Negative Pressure Wound Therapy Devices Market is expected to reach US$ 892.32 million wITH CAGR of 8.7% from 2021 to 2028 | Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann &

According to The Insight Partners market research study titled “Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Wound Type and End User,” the market is expected to reach US$ 892.32 million by 2028 from US$ 462.05 million in 2020. It is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as deterrents to its growth.

Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00020017/?openpr-10225

In terms of wound type, the single-use negative pressure wound therapy devices market is segmented into traumatic, surgical, venous leg ulcers, diabetic foot, sports injuries, and others. In 2020, the traumatic segment accounted for the highest share of the market. It is estimated to dominate the market during the forecast period. The growth of the market is attributed to factors such as increasing rate of road accidents, rising innovations in wound care products, increasing R&D activities, rising advancements in the field of wound care research, and increasing awareness about wound care treatment & management.

The global single-use negative pressure wound therapy devices market is driven by rising incidence of chronic diseases and increasing cases of burn injuries. However, the lack of effective reimbursement policies for wound care is likely to hinder the market growth.

Prominent players operating in single-use negative pressure wound therapy devices market include Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc. The companies have maximized their growth with several organic strategies to enhance the market value and maintain position in the market. For instance, in March 2020, Smith & Nephew launched its new PICO 14 Single Use Negative Pressure Wound Therapy System. It has a pump duration of up to 14 days. The pump is based on previous PICO sNPWT variants' innovations and advantages. The pump is so enhanced that it requires less user intervention. Such constant developments in the existing products are required to offer efficient product quality and services for improving patient’s health.

Market Insights

Rising Incidence of Chronic Diseases

Chronic diseases and their associated disorders are among the major indications affecting the human population globally. As per the National Center for Chronic Disease Prevention and Health Promotion, these diseases persist for one year or more and may require medical attention for performing daily activities. Moreover, as per the Centers for Disease Control and Prevention (CDC's) data in January 2021, chronic diseases such as heart disease, cancer, and diabetes are among the leading causes of morbidity, mortality, and disability in the US. It is estimated to account for ~US$ 3.8 trillion in the nation's annual health care expenses. Chronic diseases can cause long-term injuries and make the healing of wounds, such as post-surgical wounds and accident-led wounds, difficult. Different types of devices are used to manage the wounds as the wounds need to be cleaned regularly. Negative pressure wound therapy systems are used to manage and ease wound healing. It is an FDA Class II device that operates on a battery or electricity, and each device consists of a vacuum pump, drainage tubing, and wound dressing set. The systems help in wound-healing through negative pressure (suction). They also help remove fluids such as irrigation solutions, bodily liquids, wound exudate, and infectious materials present in the wound area.

According to a study published by the National Center for Biotechnology Information in August 2020, diabetic foot ulcers were among the possible causes of non-traumatic amputations in the US. About 5% of patients suffering from diabetes mellitus develop foot ulcers, and 1% need an amputation procedure. The patients in such conditions require periodic wound cleaning and dressing that can be accomplished using wound therapy devices. Continuous developments in medical devices related to wound therapy, as well as rise in prevalence of diseases such as diabetes, cancer, and diabetes—which might lead to ulcers, pressure ulcers, and wounds associated with different surgical procedures—are driving the single-use negative pressure wound therapy market.

The report segments the global single-use negative pressure wound therapy devices market as follows:

By Wound Type

Surgical
Traumatic
Diabetic Foot
Sports Injuries
Venous Leg Ulcers
Others

By End User

Hospitals
Clinics
Ambulatory Surgical Centers (ASCs)
Others

By Geography

North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
Japan
China
India
Australia
South Korea
Rest of APAC
Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00020017/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.